trifluridine has been researched along with Cardiotoxicity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aglietta, M; Bonzano, A; Cagnazzo, C; Depetris, I; Filippi, R; Leone, F; Marino, D | 1 |
Arkenau, HT; Bendell, JC; Lemech, C; Pant, S; Patel, MR; Seraj, J; Todaro, TG; Weaver, R; Yoshida, K | 1 |
Barni, S; Bertocchi, P; Petrelli, F; Zaniboni, A | 1 |
1 review(s) available for trifluridine and Cardiotoxicity
Article | Year |
---|---|
Fluoropyrimidine-induced cardiotoxicity.
Topics: Acetates; Capecitabine; Cardiotoxicity; Cardiovascular Diseases; Drug Combinations; Fluorouracil; Humans; Neoplasms; Pyrimidines; Pyrrolidines; Quinazolines; Thiophenes; Thymine; Trifluridine; Uracil; Uridine | 2018 |
1 trial(s) available for trifluridine and Cardiotoxicity
Article | Year |
---|---|
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Drug Administration Schedule; Drug Combinations; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart; Humans; Male; Middle Aged; Neoplasms; Pyrrolidines; Thymine; Trifluridine; Uracil | 2016 |
1 other study(ies) available for trifluridine and Cardiotoxicity
Article | Year |
---|---|
TAS-102, the first "cardio-gentle" fluoropyrimidine in the colorectal cancer landscape?
Topics: Cardiotoxicity; Colorectal Neoplasms; Drug Combinations; Humans; Pyrrolidines; Thymine; Treatment Outcome; Trifluridine; Uracil | 2016 |